Clinical Trial Update: Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia [NA]

View source ↗

Summary

A completed clinical trial update indicates that hypoglycemia may inhibit the insulin-secreting effect of glimepiride in individuals with Type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)

Snippet

Sponsor: Vanderbilt University | Conditions: Type 2 Diabetes | NA | Status: COMPLETED